STAT

OxyContin maker urges judges to stop release of secret marketing records

A Kentucky appeals court Monday heard arguments over whether secret records on the marketing of OxyContin should be released to the public.

FRANKFORT, Ky. — A state appeals court Monday heard arguments over whether secret records regarding the marketing of the powerful prescription opioid OxyContin should be released to the public.

A three-judge panel of the Kentucky Court of Appeals is considering a request from OxyContin maker Purdue Pharma to overturn a lower court ruling ordering the release of the documents — the result of a motion filed by STAT. The records include a deposition of Dr. Richard Sackler, a former president of Purdue and a member of the family that owns the privately held Connecticut company.

Lawyers for Purdue

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly Buying A Plant, A Pfizer Antibiotic, And More
Eli Lilly agreed to acquire a manufacturing facility in Wisconsin from Nexus Pharmaceuticals to produce injectable medicines amid shortages of Mounjaro and Zepbound.
STAT1 min read
STAT+: Nuclear Regulatory Commission Advisers Beset By Conflicts Of Interest, Report Finds
Advisers to the Nuclear Regulatory Commission, a U.S. government agency tasked with ensuring the safe use of radioactive materials, were beset by conflicts of interest, report finds

Related Books & Audiobooks